PTC Therapeutics撤回美国对杜氏肌营养不良症治疗药物Translarna的申请。
PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna
生物技术与制药领域的最新动态
PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna
Ultragenyx to lay off about 130 employees after rough 2025
Icon's stock drops 40% after disclosing internal accounting probe
AbbVie sues over selection of Botox for IRA negotiations
Pharma pushes back on FDA plans to ease prescription-OTC drug switches
Novo Nordisk to expand Irish factory for Wegovy pill
Cassidy bill seeks to ban a customs loophole on pharma's radar
Sanofi’s new CEO Belén Garijo gets frosty reception as challenges await
A pancreatic cancer approval; Seres cuts staff
Even Europeans don't see a future in Euro biopharma anymore
Terray says its AI model beats Boltz-2 at binding affinity prediction
Lyell starts first head-to-head CAR-T therapy trial
BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins
European VCs form coalition to get more support for biotech investing
Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO
Hinge Health is looking to build AI tools for mental health support
FDA may consider Moderna's flu vaccine in a narrower group
Former AstraZeneca senior staff charged with illegal trade in China
Prasad overruled vaccine review team, office director on Moderna flu shot
After CEO departs, CSL details profit crash, $1.1B impairment costs